Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hunan Hansen Pharmaceutical Co (002412) Fair Value & Analysis

Healthcare · CN · Market cap 3.0B CNY

Price¥5.89
Fair Value¥8.26
Upside+40.2%
Quality95/100
Evidence: High Range ¥5.82 – ¥10.30

Fair value as of: Jun 25, 2026

Analysis

Hunan Hansen Pharmaceutical Co (002412) currently trades at ¥5.89, while our model-based Fair Value estimate is ¥8.26 — implying the stock looks roughly 40.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is Hunan Hansen Pharmaceutical Co (002412) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥8.26 versus a price of ¥5.89 — about +40% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 002412?
Our 21-model fair value for Hunan Hansen Pharmaceutical Co is ¥8.26 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥5.89.
What is the quality score of 002412?
Hunan Hansen Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.